Skip to main content

HB 4640 — West Virginia

Relating to drugs and adding a provision relating to the scheduling of crystalline polymorph psilocybin approved by the Food and Drug Administration

Introduced 2026 session House of Delegates

This page lists STATE bills only. Open States, our source for this data, tracks state legislatures -- it has no visibility into city councils, county commissions or school boards. We don't yet have a free, storable source for local measures; see the About page for why.

Summary

  • HB 4640 is a bill in the West Virginia House of Delegates, 2026 session, introduced January 21, 2026.
  • Sponsored by Worrell, with 1 cosponsor.
  • Current status: introduced.
  • Most recent action (February 2, 2026): On 1st reading, House Calendar.
  • Subjects: Health.

Contact your legislator about this bill

Bill text & documents

Sponsors

Primary: Worrell

Cosponsors (1): Hite

History

  1. Introduced, completed
  2. Passed House of Delegates, in progress
  3. Passed Senate, not reached yet
  4. Sent to Governor, not reached yet
  5. Signed into law, not reached yet
  1. House of Delegates Filed for introduction
  2. House of Delegates To Health and Human Resources
  3. House of Delegates Introduced in House Milestone
  4. House of Delegates To House Health and Human Resources
  5. House of Delegates Markup Discussion
  6. House of Delegates By substitute, do pass
  7. House of Delegates On 1st reading, Special Calendar
  8. House of Delegates Postponed on 1st reading, Special Calendar, until January 30, 2026
  9. House of Delegates Placed on House Calendar
  10. House of Delegates On 1st reading, House Calendar Latest

Source: Open States. Last checked November 3, 2026. How we keep this accurate ›